Intellia Therapeutics, Inc. - COM (NTLA)

Q2 2024 13F Holders as of 6/30/2024

Type / Class
Equity / COM
Number of holders
286
Total Shares
90.1M
Shares change
-517K
Total reported value, excl. options
$2.02B
Value change
-$19.3M
Put/Call ratio
1.33
Number of buys
153
Number of sells
-122
Price
$22.38
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.